Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloperidone in Schizophrenia (Acute Exacerbation)
NCT00254202Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Nov 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of iloperidone in schizophrenia, sponsored by Vanda Pharmaceuticals Inc.. Started Nov 2005; status: completed.
02
Drugs
iloperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00254202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254202.